Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1104
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)